The other three proteins, MYL3, ETFA, and MDH2, revealing concordantly significant differences displayed the same trend as CA3, being more abundant in DMD patients than in BMD patients and with lowest levels in controls (Fig 4). This evidence concerns the gene MYL3 and Duchenne muscular dystrophy.